Overview

A Study to Investigate Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis

Status:
RECRUITING
Trial end date:
2030-09-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate if ataciguat slows the progression of moderate calcific aortic valve stenosis in adults.
Phase:
PHASE3
Details
Lead Sponsor:
Kardigan, Inc.
Treatments:
5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide